The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

While most gene therapy research has focused on rare disease, new results are out for a possible treatment for wet-AMD, the ...

The data were presented at the Keystone Symposium Targeting Dry Age-related Macular Degeneration: Pathophysiology and ...

It all started with a spider crawling down Ailsa Slui’s windscreen as she drove along Pakowhai Rd about 10 years ago. At ...

A recent study conducted by researchers from Shanghai Jiao Tong University School of Medicine and Fudan University has ...

There’s currently no cure or way to reverse macular degeneration. But you can slow down and prevent this eye disease from worsening and affecting your vision with treatments like eye health ...

Number 5: The FDA has approved Pavblu (aflibercept-ayyh), the fifth biosimilar referencing Eylea (aflibercept).1 The new ...

The Global Age-Related Macular Degeneration Market was valued at US$ 11.31 billion in 2023 and is expected to reach a market size of US$ 19.72 billion by 2032 at a CAGR of 7.2% During the Forecast ...

The new medication was one of two aflibercept biosimilars approved by the US Food and Drug Administration in May.

This CHMP opinion was made despite broad support for pegcetacoplan from the European retina community and multiple dissenting votes by CHMP members who supported a path to approval.” “We have seen the ...

The data were presented at the Keystone Symposium Targeting Dry Age-related Macular Degeneration: Pathophysiology and ...

About The American Macular Degeneration Foundation The American Macular Degeneration Foundation ( macular.org) is a ...